Pertussis, or whooping cough, caused by the gram-negative bacillus Bordetella pertussis, is a highly contagious, acute respiratory disease of humans. Despite high vaccination rates, this illness has re-emerged worldwide, causing approximately 300 000 deaths each year. Waning immunity after childhood immunization has resulted in a growing pool of susceptible adolescents and adults who are capable of transmitting pertussis to vulnerable unvaccinated or incompletely vaccinated infants. The hallmark symptoms of pertussis are paroxysmal coughing with whooping and post-tussive vomiting. Persistent coughing may last for weeks to months with a gradual decrease in frequency and severity. However, it should be noted that B. pertussis infections, particularly in hosts with partial immunity to the bacterium, may also follow a much milder or subclinical course. Complications that are frequently associated with classical pertussis include pneumonia, otitis media, seizures, encephalopathy, and (brain) hemorrhages.
Infectious diseases [BR:
Infections caused by beta proteobacteria
Human diseases in ICD-11 classification [BR:
01 Certain infectious or parasitic diseases
Other bacterial diseases
1C12 Whooping cough
Bordetella pertussis [GN:
Bordetella parapertussis [GN:
Pertussis pathogenicity signature, pertussis toxin
Pertussis pathogenicity signature, T1SS
Erythromycin ethylsuccinate [DR:
Erythromycin stearate [DR:
de Gouw D, Diavatopoulos DA, Bootsma HJ, Hermans PW, Mooi FR
Pertussis: a matter of immune modulation.
FEMS Microbiol Rev 35:441-74 (2011)
Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen.
Infect Genet Evol 10:36-49 (2010)
Molecular aspects of Bordetella pertussis pathogenesis.
Int Microbiol 2:137-44 (1999)
Update on pertussis in children.
Expert Rev Anti Infect Ther 8:163-73 (2010)
Pertussis in infants, children, and adolescents: diagnosis, treatment, and prevention.
Semin Pediatr Infect Dis 17:14-9 (2006)
» Japanese version
integrated database retrieval system